Share

Mexico participates in Walvax COVID-19 vaccine trials

Media Dec 7, 2021 adn40

Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.

Related Links

Walvax’s Management Member Elected to DCVMN Board

Walvax publishes safety and preliminary immunogenicity results from the Phase 1 trial of its bivalent HPV vaccine Walrinvax™ in journal Vaccine

Walvax Participated in the 24th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) in Cape Town, South Africa